1-deoxynojirimycin has been researched along with acetylcysteine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Furumai, T; Igarashi, Y; Nomura, N; Oki, T; Yamazaki, Y | 1 |
Androlewicz, MJ; Wang, Y | 1 |
Beller, M; Giese, AK; Gläser, A; Lukas, J; Pockrandt, AM; Pohlers, S; Rolfs, A; Runge, F; Seemann, S; Sharif, M; Zheng, C | 1 |
Donida, B; Dos Reis, BG; Faverzani, JL; Hammerschmidt, TG; Kessler, RG; Machado, AZ; Moura, AP; Moura, DJ; Reinhardt, LS; Sebastião, FM; Vargas, CR | 1 |
4 other study(ies) available for 1-deoxynojirimycin and acetylcysteine
Article | Year |
---|---|
Involvement of Ca2+ ion and reactive oxygen species as a mediator in pradimicin-induced apoptosis.
Topics: 1-Deoxynojirimycin; Acetylcysteine; Antibiotics, Antineoplastic; Antifungal Agents; Apoptosis; Calcium; Free Radical Scavengers; Humans; Reactive Oxygen Species; U937 Cells | 1999 |
Oligosaccharide trimming plays a role in the endoplasmic reticulum-associated degradation of tyrosinase.
Topics: 1-Deoxynojirimycin; Acetylcysteine; Alkaloids; Animals; Antigens; Calcium-Binding Proteins; Calnexin; COS Cells; Cysteine Proteinase Inhibitors; Endoplasmic Reticulum; Enzyme Inhibitors; Glucosidases; Humans; Indolizines; Mannosidases; Models, Biological; Monophenol Monooxygenase; Precipitin Tests; Time Factors | 2000 |
Enzyme enhancers for the treatment of Fabry and Pompe disease.
Topics: 1-Deoxynojirimycin; Acetylcysteine; alpha-Galactosidase; alpha-Glucosidases; Ambroxol; Bezafibrate; Enzyme Activators; Fabry Disease; Gene Expression; Glycogen Storage Disease Type II; HEK293 Cells; Humans; Leupeptins; Lysosomes; Pioglitazone; Plasmids; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Stability; Recombinant Proteins; Thiazolidinediones; Transfection | 2015 |
Cytokine profile and cholesterol levels in patients with Niemann-Pick type C disease presenting neurological symptoms: in vivo effect of miglustat and in vitro effect of N-acetylcysteine and coenzyme Q10.
Topics: 1-Deoxynojirimycin; Acetylcysteine; Antioxidants; Cholesterol; Cytokines; Enzyme Inhibitors; Humans; Inflammation; Niemann-Pick Disease, Type C; Ubiquinone | 2022 |